SCHEMBL19984544

SCHEMBL19984544

O=C(O)c1ccc2c(c1)NC(=O)C1CCCN1S2(=O)=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 4/20 0.47
ALOX15 P16050 1/20 0.47
L3MBTL1 Q9Y468 2/20 0.45
PABPC1 P11940 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
GAA P10253 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.39
POLB P06746 1/20 0.39
KDM4E B2RXH2 4/20 0.38
ALDH1A1 P00352 4/20 0.38
MAPT P10636 4/20 0.38
USP2 O75604 2/20 0.38
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
CA12 O43570 1/20 0.38
CA2 P00918 1/20 0.38
CA4 P22748 1/20 0.38
CA7 P43166 1/20 0.38
CA9 Q16790 1/20 0.38
HPGD P15428 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19984537 0.96 HSD17B10 (0.46) HSD17B10ALOX15L3MBTL1PABPC1TDP1
SCHEMBL19984555 0.84 ALOX15 (0.60) HSD17B10ALOX15L3MBTL1GAASMN1; SMN2
SCHEMBL19984542 0.81 ALDH1A1 (0.40) HSD17B10ALOX15GAASMN1; SMN2KDM4E
SCHEMBL5069696 0.78 ALDH1A1 (0.54) HSD17B10ALOX15GAASMN1; SMN2KDM4E
SCHEMBL19984618 0.78 KMT2A (0.39) HSD17B10ALOX15GAASMN1; SMN2KDM4E
SCHEMBL2505469 0.72 HSD17B10 (0.69) HSD17B10ALOX15L3MBTL1GAASMN1; SMN2
SCHEMBL19984539 0.71 HSD17B10 (0.59) HSD17B10ALOX15L3MBTL1PABPC1TDP1
SCHEMBL22300469 0.64 CA12 (0.40) HSD17B10L3MBTL1PABPC1TDP1GAA
SCHEMBL6069744 0.64 HSD17B10 (0.46) HSD17B10ALOX15L3MBTL1PABPC1TDP1
SCHEMBL22300978 0.63 CA12 (0.39) HSD17B10L3MBTL1PABPC1TDP1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220023311-A1 HEPATITIS B CORE PROTEIN MODULATORS ASSEMBLY BIOSCIENCES INC (US) 2022-01-27 US disclosed
US-20220023311-A1 HEPATITIS B CORE PROTEIN MODULATORS ASSEMBLY BIOSCIENCES INC (US) 2022-01-27 US disclosed
US-10987360-B2 Hepatitis B core protein modulators ASSEMBLY BIOSCIENCES, INC. (US) 2021-04-27 US disclosed
US-10987360-B2 Hepatitis B core protein modulators ASSEMBLY BIOSCIENCES, INC. (US) 2021-04-27 US disclosed
US-20190255067-A1 HEPATITIS B CORE PROTEIN MODULATORS ASSEMBLY BIOSCIENCES INC (US) 2019-08-22 US disclosed
US-20190255067-A1 HEPATITIS B CORE PROTEIN MODULATORS ASSEMBLY BIOSCIENCES INC (US) 2019-08-22 US disclosed
WO-2018053157-A1 HEPATITIS B CORE PROTEIN MODULATORS ASSEMBLY BIOSCIENCES, INC. (US) 2018-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10987360-B2 Hepatitis B core protein modulators HAVCR2, FABP1, MAVS HSD17B10 1394/4885ALOX15 3298/4885L3MBTL1 2994/4885
US-20190255067-A1 HEPATITIS B CORE PROTEIN MODULATORS HAVCR2, FABP1, MAVS HSD17B10 1394/4885ALOX15 3298/4885L3MBTL1 2994/4885
US-20220023311-A1 HEPATITIS B CORE PROTEIN MODULATORS HAVCR2, FABP1, MAVS HSD17B10 1394/4885ALOX15 3298/4885L3MBTL1 2994/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.